ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)
复制标题
DOI：
10.1016/j.jacc.2010.08.606
复制
发表时间：
2010-12-14
影响因子：
24
通讯作者：
Randle, Dwight
中科院分区：
文献类型：
--
作者：
Olin, Jeffrey W.;Allie, David E.;Randle, Dwight
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS外周动脉疾病性能指标编写委员会负责制定外周动脉疾病（PAD）的性能指标。这些性能指标涉及下肢和腹主动脉疾病，如ACC/AHA 2005外周动脉疾病（下肢动脉、肾动脉、肠系膜动脉和腹主动脉）患者管理指南（以下简称“PAD指南”）所述。12这些措施适用于在门诊接受评估的成年人（18岁）。编写委员会承认，由于观察性研究、登记和临床试验的贡献，该领域正在迅速发展。因此，随着外地工作的进展，有必要对考绩和发展的这些业绩计量进行修改。此外，最近血管疾病的命名也发生了变化。13.动脉粥样硬化性血管疾病一词是指由动脉粥样硬化引起的动脉（冠状动脉除外）疾病。14我们有
The ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS Peripheral Artery Disease Performance Measures Writing Committee was charged to develop performance measures for peripheral artery disease (PAD). These performance measures address lower extremity and abdominal aortic disease, as covered by the ACC/AHA 2005 Guidelines for theManagement of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)(hereafter,“PAD guidelines”). 12 The measures are intended for adults (age 18 years) evaluated in the outpatient setting. The writing committee acknowledges that the field is rapidly evolving due to the contributions of observational research, registries, and clinical trials. Hence, modifications to these performance measures for PAD will be necessary as the field advances. In addition, there has been a recent change in the nomenclature for vascular diseases. 13 The term atherosclerotic vascular disease refers to disease of the arteries (other than the coronary arteries) caused by atherosclerosis. 14 We have